Publications by authors named "Radost Vatcheva"

Claim this Profile
A
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer.
Rachel Brough, Ilirjana Bajrami, Radost Vatcheva, Rachael Natrajan, Jorge S Reis-Filho

EMBO J· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform.
Maryou B K Lambros, Paul M Wilkerson, Rachael Natrajan, Neill Patani, Vidya Pawar, Radost Vatcheva

Lab Invest· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas.
David S P Tan, Marjan Iravani, W Glenn McCluggage, Maryou B K Lambros, Fernanda Milanezi, Radost Vatcheva

Clin Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
Konstantin J Dedes, Maria-Angeles Lopez-Garcia, Felipe C Geyer, Maryou B K Lambros, Kay Savage, Radost Vatcheva

Breast Cancer Res Treat· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors.
Konstantin J Dedes, Daniel Wetterskog, Ana M Mendes-Pereira, Rachael Natrajan, Maryou B Lambros, Radost Vatcheva

Sci Transl Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers.
Rachael Natrajan, Britta Weigelt, Alan Mackay, Felipe C Geyer, Anita Grigoriadis, Radost Vatcheva

Breast Cancer Res Treat· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas.
Felipe C Geyer, Britta Weigelt, Rachael Natrajan, Maryou B K Lambros, Dario de Biase, Radost Vatcheva

J Pathol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification.
Pamela Klingbeil, Rachael Natrajan, Gemma Everitt, Radost Vatcheva, Caterina Marchio

Breast Cancer Res Treat· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
Rachael Natrajan, Maryou B K Lambros, Felipe C Geyer, Caterina Marchio, David S P Tan, Radost Vatcheva

Genes Chromosomes Cancer· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.
David S P Tan, Maryou B K Lambros, Sydonia Rayter, Rachael Natrajan, Radost Vatcheva

Clin Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiling path genomic profiling of grade 3 invasive ductal breast cancers.
Rachael Natrajan, Maryou B Lambros, Socorro María Rodríguez-Pinilla, Gema Moreno-Bueno, David S P Tan, Radost Vatcheva

Clin Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to therapy caused by intragenic deletion in BRCA2.
Stacey L Edwards, Rachel Brough, Christopher J Lord, Rachael Natrajan, Radost Vatcheva

Nature· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication timing profile reflects the distinct functional and genomic features of the MHC class II region.
Petros Takousis, Peter Johonnett, Jill Williamson, Peter Sasieni, Gary Warnes, Radost Vatcheva

Cell Cycle· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling identifies discrete deletions associated with translocations in glioblastoma multiforme.
Paul J Mulholland, Heike Fiegler, Chiara Mazzanti, Patricia Gorman, Peter Sasieni, Radost Vatcheva

Cell Cycle· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes.
Sarah Drayton, Janice Rowe, Rebecca Jones, Radost Vatcheva, Darren Cuthbert-Heavens

Cancer Cell· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment of heterogeneous nuclear ribonucleoprotein A1 in vivo to the LMP/TAP region of the major histocompatibility complex.
Rossen Donev, Roger Horton, Stephan Beck, Teodora Doneva, Radost Vatcheva

J Biol Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.
Sharon Brookes, Janice Rowe, Margarida Ruas, Susana Llanos, Paula A Clark, Radost Vatcheva

EMBO J· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis